Applications of Gene Editing and its Societal Impact
A panel discussion including UC San Diego Chancellor Pradeep Khosla and molecular biology professor Suresh Subramani and two other experts will discuss applications of gene editing and its societal impact. The panel is part of a TiE South Coast monthly event in connection with a groundbreaking partnership between UC San Diego and the TATA Foundation.
The program will outline the phenomenal work that the panel is doing in CRISPR Gene Editing Technology and its implications in the health care arena. All four experts on the panel are now affiliated with the Tata Institute for Genomics and Society, a partnership of UC San Diego researchers and funding from the TATA Foundation.
TiE South Coast is a non-profit volunteer-run chapter of the TiE global networking organization that exists to nurture entrepreneurship.
Chancellor Pradeep K. Khosla is UC San Diego’s eighth Chancellor, and is an internationally renowned electrical and computer engineer recognized for his seminal contributions in secure software, intelligent robot systems and design. He provides vision and strategy for the university, leading a campus with more than 35,000 students, six undergraduate colleges, five academic divisions, five graduate and professional schools, a preeminent Health System and the prestigious Scripps Institution of Oceanography.
Dr. Suresh Subramani is a Distinguished Professor of Molecular Biology. He received his Ph.D. (Biochemistry) at UC Berkeley, and was a postdoctoral fellow (Biochemistry) at Stanford University with Nobel laureate, Dr. Paul Berg. Dr. Subramani is world renowned for his work on the assembly and disassembly of subcellular compartments, notably peroxisomes, and the role of these processes in disease. Dr. Subramani also has extensive administrative experience, including his service as the first Executive Vice Chancellor (EVC) at UC San Diego from 2010-2016. He is currently the Global Director for the Tata Institute for Genetics and Society (TIGS) overseeing research in India and at UC San Diego.
Dr. Anthony James, PhD, is Donald Bren Professor of Microbiology & Molecular Genetics (School of Medicine) and Molecular Biology & Biochemistry (Francisco J. Ayala School of Biological Sciences) at the University of California, Irvine (UCI). He is a member of the National Academy of Sciences (USA). Dr. James received his bachelors of science and PhD degrees at UCI. He went to Boston in 1979 for postdoctoral work (Harvard Medical School and Brandeis University) and joined the faculty at the Harvard School of Public Health in 1985
Dr. Valentino Gantz, PhD, is an Assistant Research Scientist in the Division of Biological Sciences at UC San Diego. He received his PhD in Biology from UC San Diego where he tested a new application of the CRISPR/Cas system. The resulting technology, the mutagenic chain reaction or MCR, is a new method that allows MCR-type "active" genetic elements to be propagated at double the expected frequency. In brief, in the germline of animals heterozygous for an "active" transgene, the element is capable of converting the second chromosome leading to homozygosity. This genetic behavior, also known as gene drive, holds great promis
ONLINE EVENT FEE:
$20 for Student TiE members (ID required)